Page results
-
Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
The Sickle Cell Society (SCS) and the UK Thalassaemia Society (UKTS) have worked in partnership with the NHS sickle cell and thalassaemia (SCT) screening programme to engage with communities less likely to access health information through usual NHS channels. The societies provide feedback from people that share the same population background or have experience of the condition and to feed into the programme updates and improvements.
-
This page explains what a gastroscopy is and what it involves for patients on a prolonged diet.
-
The hospital marked the start of the year a visit by HM The Queen in February 2020. A few weeks after this celebration, the pandemic took hold and the hospital stepped up to help.
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
UCLH and Whittington Health have a long history of working together to benefit patients, staff and our communities across Camden, Haringey, Islington and beyond. This includes services such as the virtual ward, orthopaedic surgery and paediatric dentistry.
-
UCLH has treated the first brain cancer patient with immunotherapy prior to standard treatment as part of a pioneering trial.
-
UCLH is making the change from single use to named reusable fabric theatre hats for staff working in operating theatres.
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
